Charles Sternberg, Associate Editor04.04.23
MOLLI Surgical, a company pushing the boundaries of precision surgery, has launched two new products: MOLLI 2 and MOLLI re.markable.
The latest products, including a tool that ensures lesions are accurately marked, are paving the way for the next generation of healthcare. They deliver on the company's commitment to elevate the patient experience, refine precision surgery, and boost physicians’ confidence.
The wire-free technology includes the MOLLI Marker — about the size of a sesame seed — that can be detected using MOLLI 2. The MOLLI Marker precisely marks where lesions are located before breast cancer surgery. The MOLLI Tablet then displays the distance — and now direction — between the tip of MOLLI 2 and the MOLLI Marker in millimeters.
MOLLI 2 is easy to use, reliable, and precise, delivering improved efficiency and improving patient outcomes.
“At MOLLI Surgical, we're constantly refining, innovating, and driving the future of healthcare by addressing the real clinical problems facing healthcare teams. The release of these two new products demonstrates our continued rapid pace of evolution in our technology,” said Ananth Ravi, president and CEO of MOLLI Surgical. “Our approach to innovation has always kept patient experience at the forefront. The launch of MOLLI 2 and MOLLI re.markable will improve the patient experience by creating the simplest possible process for accurate breast surgery.”
MOLLI Surgical’s new products are now available to surgeons and radiologists.
The latest products, including a tool that ensures lesions are accurately marked, are paving the way for the next generation of healthcare. They deliver on the company's commitment to elevate the patient experience, refine precision surgery, and boost physicians’ confidence.
MOLLI 2
MOLLI 2 is an evolution in MOLLI Surgical’s award-winning platform technology that allows surgeons to pinpoint cancerous tissue for faster, more accurate, and potentially improved cosmesis while significantly improving the patient experience.The wire-free technology includes the MOLLI Marker — about the size of a sesame seed — that can be detected using MOLLI 2. The MOLLI Marker precisely marks where lesions are located before breast cancer surgery. The MOLLI Tablet then displays the distance — and now direction — between the tip of MOLLI 2 and the MOLLI Marker in millimeters.
MOLLI 2 is easy to use, reliable, and precise, delivering improved efficiency and improving patient outcomes.
MOLLI re.markable
MOLLI re.markable is a new tool helping physicians accurately mark lesions by allowing radiologists and surgeons to reposition a localization marker with minimal impact or discomfort for patients. If the original placement was suboptimal, the localization marker can be removed without requiring invasive surgery or a large biopsy needle.“At MOLLI Surgical, we're constantly refining, innovating, and driving the future of healthcare by addressing the real clinical problems facing healthcare teams. The release of these two new products demonstrates our continued rapid pace of evolution in our technology,” said Ananth Ravi, president and CEO of MOLLI Surgical. “Our approach to innovation has always kept patient experience at the forefront. The launch of MOLLI 2 and MOLLI re.markable will improve the patient experience by creating the simplest possible process for accurate breast surgery.”
MOLLI Surgical’s new products are now available to surgeons and radiologists.